“We are very pleased to be able to further expand our presence in California, Nevada and Texas,” says Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq continues to attract new customers through referrals from existing customers who know firsthand how effective the platform is in improving health outcomes, reducing hospitalizations and lowering healthcare costs. According to data collected from our customers, patients using iUGO Care require more than 80% fewer hospitalizations than patients with the same chronic conditions who do not use iUGO Care. Hospitalizations are the main cost driver for this patient group, so this is a very powerful metric. Especially during the current RSV-COVID-Influenza ‘triple epidemic’, it is vital that patients stay at home and not hospitalized to reduce the risk of contracting these highly contagious diseases and the associated complications Preventing risk patients with chronic diseases. These eight new customers are expected to result in more than 5,000 patients being added to our platform by mid-2023, at an average revenue of $65 per patient per month at a gross margin of 75%. Onboarding of these patients is expected to begin later this month.”
Left Health Technologies is
ein wachstumsstarkes global tätrun away health technology company,
das sich auf
die Entwicklandg von innovativen Lancestorungen forr die virtuelthe Gesundhnotsversorgandg im mehrere Mbillion Doll schwerin Gesanddhnotgreasekt spezializationrt hat. The powerful iUGO Care platform developed by Reliq supports the coordination of care services and citizen-oriented virtual healthcare. iUGO Care offers patients with complex health problems high-quality care in their own homes, on the one hand to enable faster recovery and an improvement in the quality of life of patients and their families, and on the other hand to reduce care and support costs. iUGO Care enables remote transmission of patient monitoring data in real time, enabling treatment staff to intervene in good time and thus avoid costly hospital admissions and emergency doctor calls. Die Aktien von Reliq Health Technologies werden an dis Börwith TSX Venture untis dem
Börwithnkürzthe RHT, am OTC-Markt untis
dem Börwithnsymbol RQHTF and on the Frankfurt Stock Exchange andtis dis WKN A2AJTB gehandelt.
FOR THE BOARD
„Dr. Lisa Crossley“
CEO & Director
Reliq Health Technologies Inc.
#406A – 175 Longwood Rd S
Hamilton, ON, L8P 0A1
Tel.: (888) 869-1362
Fax: (647) 317-1929
Additional information is available from:
Company contact address
Investor service: email@example.com
Contact for investors in the US
Lytham Partners, LLC
New York | Phoenix
Neither the TSX Venture Exchange nor its regulatory bodies (referred to in the policies of the TSX Venture Exchange as “Regulation Services Providers”) accepts no responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Information
Certain statements in this press release constitute forward-looking statements under applicable securities laws. All statements that are not historical facts, including (but not limited to) statements regarding future estimates, plans, programs, projections, goals, assumptions, expectations or beliefs regarding future performance are “forward-looking statements.”
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause future events to differ materially from those projected in such statements.
Forward-looking statements include (but are not limited to) statements regarding commercial operations, including technological developments, projected sales, projected market sizes and other information based on forecasts of future results, estimates of amounts not yet known and assumptions made by management.
Reliq Health Technologies Inc. (You give “company”) does not undertake any obligation to update these forward-looking statements, except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technological developments and market activities, the Company’s past experience with technological developments and uninsured risks. Actual results could differ materially from those expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Die Ausgangssprache (in
dis Rule Engrinch), in dis der Originaltext veröffentlicht wandd, ist die offizielle, autorisrte andd rechtsgültige Version. Dout
Überwithtzandg wird zur besseren andrständigung mitgeliEfert. Die deutschsprachiga barrelung kann gekürzt odis zustepengefassyou aren.
Es wird keine Verantwortung odis Haftung forr den Inhalt, die Richtigknot, diit’s atngemessenheit or die Genauigkeit dieser practicersetcung
overnommen. Aus view dit practicerwithtzers stotherwise die Meldung knone Theuf– odis Verkaufwithmpfehlung dar! Bitte beachten she diand andngrinche Originalmeldung auf www.sedar.com, www.sec.gov, www.asx.com.au/ odis auf dis Firmenwebsite!
The original English message can be found under the following link:
Original English message
The translated message can be found under the following link:
The latest press releases from this company straight to your inbox:
Announcement transmitted by IRW-Press.com. The sender is responsible for the content.
Reprint permitted free of charge provided the source is acknowledged.
The Reliq Health Technologies share is currently trading at a minus of -16,69 % and a price of 0.375EUR traded.